Back to results
US 10,136,649 B2Granted
Methods for screening bacteria, archaea, algae, and yeast using CRISPR nucleic acids
AssigneeNorth Carolina State University
InventorsRodolphe Barrangou, Kurt M. Selle
Life of this patent
Estimating the term…
Abstract
This invention relates to the use of CRISPR nucleic acids to screen for essential and non-essential genes and expendable genomic islands in bacteria, archaea, algae and/or yeast, to kill bacteria, archaea, algae and/or yeast, to identify the phenotype of a gene or genes, and/or to screen for reduced genome size and/or a gene deletion in bacteria, archaea, algae and/or yeast.
Claims8
A method of killing a wild-type bacterial cell having a functional endogenous Cascade-Cas3 CRISPR system within a population of bacterial cells, comprising:
- introducing into the population of bacterial cells a heterologous nucleic acid construct comprising a Cascade-Cas3 CRISPR array (crRNA, crDNA) comprising (5′ to 3′) a repeat-spacer-repeat sequence or a repeat-spacer sequence,
- wherein the spacer of said repeat-spacer-repeat sequence or said repeat-spacer sequence comprises a nucleotide sequence that is 100% complementary to a target sequence of the wild-type bacterial cell, the target sequence having at least 10 consecutive nucleotides adjacent to a protospacer-adjacent motif (PAM) recognized by the functional endogenous Cascade-Cas3 CRISPR system,
- thereby killing the wild-type bacterial cell within the population of bacterial cells;
- provided that the following are not introduced into the population of bacterial cells:
- (a) an exogenous Cas3 polypeptide that recognizes a complex of Cascade and the Cascade-Cas3 CRISPR array, and an exogenous nucleic acid construct encoding said exogenous Cas3 polypeptide;
- and
- (b) an exogenous Cascade polypeptide that recognizes the Cascade-Cas3 CRISPR array, and an exogenous nucleic acid construct encoding said Cascade polypeptide.
4 more elements
Dependencies are inferred from the claim text.